Hikma Pharmaceuticals

SUMATRIPTAN SUCCINATE

  1. Home
  2.  / 
  3. J Code
  4.  / SUMATRIPTAN SUCCINATE – J3030

Manufacturer:

Hikma Pharmaceuticals

Name:

SUMATRIPTAN SUCCINATE

HCPCS Code Descriptor:

Injection, sumatriptan succinate, 6 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)

Category:

J Code

HCPCS:

J3030

NDC(s):

70594-0068-02, 70069-0804-01, 70069-0804-05, 55150-0173-01, 16714-0040-02, 00245-0809-89, 00245-0809-38, 00173-0739-02, 00173-0739-00, 00173-0479-00, 00173-0478-00, 00173-0449-02, 00143-9638-05

Primary Type:

Neurology

Generic Status:

Multi-Source

Route of Administration:

Subcutaneous

About:

SUMATRIPTAN SUCCINATE is a Neurology drug manufactured by Hikma Pharmaceuticals and administered via the Subcutaneous route of administration. The J Code: J3030 is aligned to the drug SUMATRIPTAN SUCCINATE.

Access Pricing and More By Registering

HCPCS Added Date:

1/1/86

HCPCS Effective Date:

1/1/00

HCPCS Short Description:

Sumatriptan succinate / 6 mg

Billing and Coding Guide:

Not Found

Patient Assistance:

http://www.gskforyou.com/